9.50 USD
↘ 0.17 (1.76%)AT CLOSE (03:59 PM EDT)
PUMA BIOTECHNOLOGY INC
PBYINASDAQ • USD
9.51
↗ 0.01 (0.11%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
9.51
↗ 0.01 (0.11%)
Market: CLOSED
PUMA BIOTECHNOLOGY INC (PBYI) trades at $9.51 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a concerning Altman Z-Score in the distress zone and a bullish Golden Cross on the moving averages. Valuation metrics suggest PBYI is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 6, 2026.
Open?$9.72
High?$9.80
Low?$9.43
Prev. Close?$9.67
Volume?322.7K
Avg. Volume?314.4K
VWAP?$9.56
Rel. Volume?1.03x
Bid / Ask
Bid?$8.17 × 100
Ask?$10.99 × 100
Spread?$2.82
Midpoint?$9.58
Valuation & Ratios
Market Cap?499.2M
Shares Out?51.6M
Float?38.4M
Float %?74.5%
P/E Ratio?18.68
P/B Ratio?3.60
EPS?$0.52
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Employees
179
Market Cap
499.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-03-21
Address
10880 WILSHIRE BLVD.
LOS ANGELES, CA
Phone: (424) 248-6500
LOS ANGELES, CA
Phone: (424) 248-6500
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?0
Momentum?88
Short Sent.?28
Piotroski F-Score?6/9Mixed
Altman Z-Score?-1.45Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?11.24%High
Short Interest?4.3M
Days to Cover?13.8
Free Float38.4M
Avg Daily Volume313.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?2.91Strong
Quick Ratio?2.64Strong
Cash Ratio?0.73Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 3 peers + S&P 500
Score89/100
P/E?18.7FAIR▾
Peers50
S&P69
P/B?3.60FAIR▾
Peers50
S&P48
P/S?2.16CHEAP▾
Peers100
S&P63
P/FCF?12.1CHEAP▾
Peers100
S&P83
EV/EBITDA?11.3CHEAP▾
Peers50
S&P72
EV/Sales?2.00CHEAP▾
Peers100
S&P75
Returns & Efficiency
ROE?19.3%STRONG▾
Peers50
S&P64
ROA?13.9%STRONG▾
Peers50
S&P84
Cash Flow & Enterprise
FCF?$41.1M
Enterprise Value?$462.6M
Fundamentals ratios updated end of day